Research and Development

Kay O’Hagan has joined commercial packaging and clinical trials supply services company Brecon Pharmaceuticals as director of quality assurance and …

GlaxoSmithKline has unveiled a partnership with a ‘superstar academic’, as part of a new strategy which it believes will help …

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …

Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …

Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …

An investigational antipsychotic drug being developed by Forest Laboratories and Budapest-based Gedeon Richter has failed to prove itself in phase …

Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …

SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …

The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …

Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …

The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …

Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …